Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial
Part of paid clinical trials in University Park, Pennsylvania.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT06926062
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Human Papillomavirus-Related Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Best Practice — OTHERProvide vaccinations per usual care
- Educational Intervention — OTHERReview messages on safety and side effects
- Educational Intervention — OTHERReview messages on vaccine effectiveness
- Educational Intervention — OTHERReview messages on sexual activity
- Educational Intervention — OTHERReview messages on HPV vaccine for boys
- Educational Intervention — OTHERReview message on age to start vaccine
- Educational Intervention — OTHERReview messages on school entry requirements
- Interview — OTHERAncillary studies
- Questionnaire Administration — OTHERComplete a survey
- Questionnaire Administration — OTHERAncillary studies
- Training and Education — BEHAVIORALReceive interpersonal communication training
- Training and Education — BEHAVIORALReceive the vaccination workflow training
- Vaccination — PROCEDUREProvide vaccinations using the interpersonal communication strategy
- Vaccination — PROCEDUREProvide vaccinations using the vaccination workflow training strategy
- Vaccination — PROCEDUREProvide vaccinations using both the interpersonal communication strategy and the vaccination workflow training strategy
Study Details
This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccination in the United States has placed unvaccinated children at risk of developing cancers as adults that could have been prevented. Pharmacies can be convenient for vaccination because they are open longer hours, have shorter wait times, can see patients without appointments and may cost less. However, many people are not aware that vaccination is available in pharmacies and some pharmacies lack the commitment from staff to vaccinate or may not have protocols in place for vaccination. Proactive communication approaches to recommending HPV vaccination have been shown to be effective in medical offices but have not been tested in the pharmacy setting. Interpersonal communication training incorporates the 5 A's (assess, advice, agree, assist and arrange) behavioral counseling framework to strongly recommend HPV and other vaccines and effectively answer any questions or concerns about vaccination. Vaccination workflow training establishes vaccination decision support strategies that pharmacies use to improve vaccination workflows. Interpersonal communication training and vaccination workflow training alone or in combination may improve communication and recommendations for HPV vaccination and increase HPV vaccination in pharmacies.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Jul 2025
- Primary completion
- Sep 1, 2026
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 1,900 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Other: Objective 1, Topic I (safety and side effects survey)Parents review 4 messages on safety and side effects and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Other: Objective 1, Topic II (vaccine effectiveness survey)Parents review 4 messages on vaccine effectiveness and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Other: Objective 1, Topic III (sexual activity survey)Parents review 4 messages on sexual activity and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Other: Objective 1, Topic IV (HPV vaccine for boys survey)Parents review 4 messages on HPV vaccine for boys and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Other: Objective 1, Topic V (age to start vaccine survey)Parents review 4 messages on age to start vaccine and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Other: Objective 1, Topic VI (school entry requirements survey)Parents review 4 messages on school entry requirements and complete a survey over 15-20 minutes in support of intervention refinement on study.
- Active Comparator: Objective 2, Group I (control)Pharmacy staff provide vaccinations per usual care.
- Experimental: Objective 2, Group II (strategy A)Pharmacy staff receive interpersonal communication training over 120 minutes and provide vaccinations using the interpersonal communication strategy.
- Experimental: Objective 2, Group III (strategy B)Pharmacy staff receive the vaccination workflow training and provide vaccinations using the vaccination workflow training strategy.
- Experimental: Objective 2, Group IV (strategies A and B)Pharmacy staff receive interpersonal communication training as well as vaccination workflow training and provide vaccinations using both the interpersonal communication strategy and the vaccination workflow training strategy.
Primary Outcome Measure
Perceived fit, relevance, or compatibility of human papillomavirus (HPV) vaccination or the communication strategy for a given practice site, provider, or patient (Appropriateness: Pharmacy Staff) [ Time Frame: At baseline, 2 months post-training delivery, and 12 months post-training delivery ]
Central Contacts
- Morgan Glascock206-667-7438
- Kate Watabayashi206-667-5624
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Penn State University | University Park | Pennsylvania | 16802 | William A. Calo, PhD, JD, MPH (PRINCIPAL_INVESTIGATOR) |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Jennifer Bacci, PharmD, MPH, BCACP (PRINCIPAL_INVESTIGATOR) |
Find similar trials in University Park, PA
Related Studies
- Testing RG1-VLP Vaccine to Prevent HPV-related CancersPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax TrialRecruiting · Emory University · Atlanta, Georgia